News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Fadi Haddad: Happy to present data on the role of inotuzumab in patients with B-ALL at ASH24
Fadi Haddad/X
Dec 12, 2024, 14:22

Fadi Haddad: Happy to present data on the role of inotuzumab in patients with B-ALL at ASH24

Fadi Haddad, Assistant Professor in the Department of Leukemia at the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Happy to present data from MD Anderson Cancer Center on the role of inotuzumab in eradicating MRD in patients with B-ALL at ASH24:-

  • N=30
  • 67% response rate, MRD conversion
  • 3-year OS 56%
  • Low grade AEs, but 2 SOS (both in patients with ponatinib, Gr 5=1).”

Fadi Haddad is an Assistant Professor in the Department of Leukemia at the Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center in Houston, TX. He serves as a member of the Leading Clinical Research Faculty Learning Series. His postgraduate training includes a clinical fellowship in leukemia at MD Anderson Cancer Center and a clinical residency in hematology/oncology at Hotel Dieu de France Hospital in Beirut.

ASH24 cancer Cancer Medicine Fadi Haddad fight against cancer Global fight against cancer Happy Inotuzumab Leukemia MD Anderson Cancer Center MRD OncoDaily Oncology University of Texas
Special Coverage
Blog
Apr 15, 2025, 19:08
Parminder Singh: Hitting our fundraising goal for this year at the Hope Foundation for Cancer Research
Positive
Apr 15, 2025, 18:57
The launch of the SIOP Global Mapping Project in Oceania - Young SIOP
Science
Apr 15, 2025, 18:41
Clara Park: ASCO guideline on sentinel lymph node biopsy in early-stage breast cancer
Blog
Apr 15, 2025, 18:40
Join the 27th ESGO 2026 in Copenhagen - European Society of Gynaecological Oncology
Blog
Apr 15, 2025, 18:26
Katie Coleman: What is the cause of kidney cancer?
Blog
Apr 15, 2025, 18:25
Cristina Carrera Álvarez: Back from the motivating 11th WCM2025 and 21st Annual Meeting of the EADO
Blog
Apr 15, 2025, 18:11
Rachna Shroff: Honored to Speak at the Brazilian Group of Gastrointestinal Tumors Meeting
Science
Apr 15, 2025, 18:09
Nieves Martinez Lago: Spanish consensus on the diagnosis and management of ACC
Blog
Apr 15, 2025, 17:59
New guidance for managing gastrointestinal symptoms from cancer treatment - Digestive Cancers Europe
Blog
Apr 15, 2025, 17:49
Michael Hofman: Registrar fellowships positions at Peter MacCallum Cancer Centre
Blog
Apr 15, 2025, 17:48
Sylvester Comprehensive Cancer Center’s 4th Biennial Miami Leukemia Symposium launches next weekend
Blog
Apr 15, 2025, 17:41
Dana is an ALK Positive volunteer who diagnosed in 2020